Related Experiment Video

Updated: Aug 25, 2026

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
09:45

Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke

Published on: March 22, 2016

The role of cardiovascular risk factors in Alzheimer's disease

Ramit Ravona-Springer1, Michael Davidson, Shlomo Noy

  • 1Memory Clinic, Sackler School of Medicine, Tel Aviv University, Israel. ramit.ravona@sheba.health.gov.il

CNS Spectrums
|January 1, 2004
PubMed

Insights

Recent studies blur the lines between Alzheimer's disease (AD) and vascular dementia. Cardiovascular risk factors are now linked to both, challenging traditional distinctions and impacting future dementia research and treatment.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Gerontology

Background:

  • Alzheimer's disease (AD) and vascular dementia are the most common forms of dementia.
  • Recent research challenges the clear distinction between AD and vascular dementia.
  • Cardiovascular risk factors were traditionally used to differentiate these conditions.

Purpose of the Study:

  • To explore the role of cardiovascular risk factors in Alzheimer's disease.
  • To explain the overlap observed between Alzheimer's disease and vascular dementia.
  • To discuss the implications for differential diagnosis, research, and treatment strategies.

Main Methods:

  • Review of epidemiologic, clinical, imaging, and neuropathological studies.
  • Analysis of the association between cardiovascular risk factors and dementia types.
  • Proposed mechanisms of action for cardiovascular risk factors in AD.

Main Results:

  • Cardiovascular risk factors are associated with both Alzheimer's disease and vascular dementia.
  • The traditional criteria for distinguishing between AD and vascular dementia are increasingly undermined.
  • Evidence suggests a complex interplay between vascular health and neurodegenerative processes in AD.

Conclusions:

  • The distinction between Alzheimer's disease and vascular dementia requires re-evaluation.
  • Cardiovascular risk factors play a significant role in both conditions.
  • Future strategies for dementia diagnosis and treatment must consider this overlap.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice06:34

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice

Published on: June 2, 2023

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...